AEVR Announces First-Ever Thyroid Eye Disease Congressional Briefing

(Washington, D.C.) Today, the Alliance for Eye and Vision Research’s (AEVR) Decade of Vision 2010-2020 Initiative announced its first Congressional Briefing on Thyroid Eye Disease, to be held on Thursday, November 14, 2019, from 12 Noon to 1:15 pm in the House Rayburn Office Building Room 2075. RSVP to Dina Beaumont at 202-407-8320 or [email protected].

Thyroid eye disease (TED) is a serious, debilitating, and vision-threatening autoimmune disease where the immune system attacks muscles and other tissue behind and around the eyes. TED has active and inactive phases. Currently, there is no approved therapy to treat TED. Current treatment during active TED consists of corticosteroids and ocular lubricants, which only treat the symptoms. As a result, physicians must wait for progression to inactivity and for inflammation to subside to perform complex surgical procedures that may be associated with additional complications, depending on the severity of symptoms. People living with TED frequently experience long-term functional, psychosocial, and economic burdens, including inability to work and perform activities of daily living.

The National Institutes of Health (NIH) through its National Eye Institute (NEI) is funding research into TED, as is private industry. 

The Briefing features Raymond Douglas, MD, PhD, a board-certified oculoplastic surgeon in Beverly Hills, California who serves as the Director of the Orbital and Thyroid Eye Disease Program at Cedars-Sinai Medical Center in Los Angeles, California. Patients from around the country with thyroid eye disease, previous unsuccessful eyelid surgery (blepharoplasty), cancers of the eyelids and face, and trauma-induced injuries all seek his expert care. In his presentation, Dr. Douglas will focus on his research and clinical trials for treatments of TED.

Alliance for Eye and Vision Research (AEVR), a 501(c)3 non-profit foundation, is proud to announce these educational programs associated with its Decade of Vision 2010-2020 Initiative, a sustained educational effort acknowledged by Congress that recognizes the benefits of federally funded vision research. Visit its Web site at